Frontlight ResearchEarly access
Trial site
Tirol Kliniken GmbH
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Childhood cancers1 trial
- Follicular lymphoma1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Primary biliary cholangitis1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Abscint NV/SA1 trial
- Gilead Sciences1 trial
- Insel Gruppe AG, University Hospital Bern1 trial
- Nektar Therapeutics1 trial
- Regeneron Pharmaceuticals1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Recruiting
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Active, not recruiting
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Follicular lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Primary biliary cholangitis1 recruiting
- Stroke1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026